Get started Log in

TCRR — TCR2 Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Brief: Tcr² Therapeutics Reports Q1 2020 Financial Results
14/05/2020 11:51
Brief: Tcr² Therapeutics Says Stephen Webster Joins Its Board Of Directors
04/05/2020 13:07
Brief: TCR2 Therapeutics Files For Mixed Shelf Offering Of Up To $300 Mln
06/03/2020 22:49
Brief: TCR² Therapeutics Reports Q3 Loss Per Share Of $0.58
12/11/2019 12:25
U.S. STOCKS ON THE MOVE-Avedro, Kraft Heinz, TMX Group
08/08/2019 18:53
TCR2 Therapeutics shares rise after cancer drug trial update
08/08/2019 16:24
Brief: TCR2 Therapeutics Qtrly Loss Per Share $0.46
08/08/2019 12:15
Brief: TCR² Therapeutics Reports Q2 Loss Per Share $0.46
08/08/2019 12:13
Brief: TCR2 Therapeutics Added To Russell 2000, 3000 And Microcap Indexes
28/06/2019 13:05
Brief: Tcr2 Therapeutics Reports Qtrly Net Loss Per Share Attributable To Common Stockholders, Basic And Diluted $4.85
13/05/2019 22:49
Brief: TCR2 Therapeutics Publishes First Peer-Reviewed Data Demonstrating Superior Anti-Tumor Activity Of Co's Novel TRuC-T Cells
07/05/2019 10:18
Brief: Tcr2 Therapeutics QTRLY Loss Per Share $16.22
01/04/2019 12:35
Tcr2 Therapeutics: Rises on cancer therapy tie-up with CGT Catapult
26/03/2019 18:43
Brief: TCR2 Therapeutics Announces Collaboration With Cell And Gene Therapy Catapult For The Manufacturing Of Its Novel T Cell Therapies For Cancer
26/03/2019 11:24
U.S. RESEARCH ROUNDUP-Avedro, FireEye, HCI Group
11/03/2019 07:17
Advisory: Alert on TCR2 Therapeutics Wrongly Coded To Broker Research
27/02/2019 24:37
Brief: Tcr2 Therapeutics Announces Exercise Of Over-Allotment Option
26/02/2019 22:31
Brief: Upnorth Investment Limited Reports 9.2 Pct Passive Stake In Tcr2 Therapeutics Inc As Of Feb 13, 2019 - SEC Filing
22/02/2019 11:26
NASDAQ RESUMED
14/02/2019 16:10
NASDAQ TRADE HALT REASON NOT AVAILABLE
14/02/2019 09:00